THE FIRM This powerhouse has an excellent reputation for M&A work in Pennsylvania, with offices in both Philadelphia and Pittsburgh. Acting for both regulated and unregulated companies the group offers a full service to its clients. The team wins recognition for its expertise in life sciences and has a deep bench of securities lawyers upon which it can rely. The group attracts a wide variety of clients ranging from private equity sponsors to emerging growth companies and strategic acquirers. GlaxoSmithKline, NutriSystem and AmerisourceBergen are counted among the firm's clientele.
Sources say: "They staff leanly for a large firm; they are efficient and exercise good authority."
KEY INDIVIDUALS David Gerson wins high praise for his thoughtfulness and skill in problem solving. He represents private equity funds and has particular experience in acting on behalf of both purchasers and vendors. One commentator says: "He was tremendously diligent with our transactions and did a great job dealing with the nuances of the case."
Stephen Goodman is universally acknowledged as "the godfather for entrepreneurs in this region," and the "dean of emerging growth companies."
Heading the M&A practice is Richard Aldridge, who is accorded recommendations for his efficiency, with clients noting: "He focuses diligently on our deals and brings together a really good team." He has been active in the healthcare and pharmaceuticals industry recently. In addition to this, a recent highlight was advising GSI Commerce on its merger with eBay, where GSI's stock was bought for $2.4 billion.
Marlee Myers is the managing partner of the firm's Pittsburgh office. Her primary area of expertise lies in representing strategic acquirers, though she has extensive experience dealing in emerging growth sectors such as e-commerce and clean energy. She recently acted on behalf of long-standing client US Steel on the sale of an indirect subsidiary, Mobile River Terminal Energy.
Alan Singer is praised for his "encyclopedic knowledge" of securities. His practice ranges from advising publicly traded companies on their SEC filings, to regulatory compliance and the integration of public and private offerings. He recently led the team acting for UniTek's public offering, which was valued at just over $90 million.
James McKenzie is a member of both the M&A and securities practices at this firm. Highlights include representing the underwriters on Digital Domain Media's IPO, and acting for a pharmaceutical company, NuPathe, on its IPO, valued at $50 million. He earns plaudits from peers, who say: "He is incredibly smart and practical in his application of the law."
Joanne Soslow enters the rankings this year following extensive praise from the market, with sources describing her as "a fabulous securities lawyer." Her practice focuses on public companies and emerging growth companies in a variety of sectors including manufacturing and pharmaceuticals.
Since publication, W Ryan Davis has left this practice.